Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Faster-acting Insulin Aspart in T1D Pumps
NCT03215498Phase 1Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2017
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin aspart in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Area under the insulin aspart curve 0-30 min. Started Jul 2017; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03215498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03215498.